Psychiatric comorbidities among iranian elderly patients on methadone maintenance treatment

Archives of Iranian Medicine

Volumn 18, Issue 11, 2015, Pages 740-746

  Mortazavi, Seyede Salehe ^a   Shati, Mohsen ^b   Malakouti, Seyed Kazem ^a   Mohammad, Kazem ^c  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Comorbidity; Elderly; Mental health; Substance abuse

Indexed keywords

ALCOHOL; METHADONE; OPIATE;

ADULT; AGED; ALCOHOL ABUSE; ANXIETY DISORDER; ARTICLE; COMORBIDITY ASSESSMENT; CROSS-SECTIONAL STUDY; DRUG ABUSE PATTERN; FEMALE; HUMAN; INCIDENCE; IRANIAN PEOPLE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; METHADONE TREATMENT; MIDDLE AGED; MOOD DISORDER; PREVALENCE; PSYCHIATRY; RECALL BIAS; RISK FACTOR; SEMI STRUCTURED INTERVIEW; STRUCTURED QUESTIONNAIRE; SUBSTANCE ABUSE; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; IRAN; MENTAL HEALTH; MULTIVARIATE ANALYSIS; OPIATE SUBSTITUTION TREATMENT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUESTIONNAIRE; STATISTICAL MODEL; SUBSTANCE-RELATED DISORDERS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; IRAN; LOGISTIC MODELS; MALE; MENTAL HEALTH; METHADONE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OPIATE SUBSTITUTION TREATMENT; PSYCHIATRIC STATUS RATING SCALES; SUBSTANCE-RELATED DISORDERS; SURVEYS AND QUESTIONNAIRES;

EID: 84944747986     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Levine HG. The discovery of addiction: Changing conceptions of habitual drunkenness in America. Journal of Substance Abuse Treatment. 1985; 2(1): 43-57.
2. Rahimi MA, Sharifi V, Mohammadi MR, Farhoudian A. Researches on substance use in Iran; 3 decades evaluation. Hakim. 2006; 8(4): 37-44.
3. Sadock BJ, Sadock VA. Kaplan and sadock’s comprehensive textbook of psychiatry. 8th ed. New York: Lippincott Williams and Wilkins; 2005.
4. Hannesdottir H, Tyrfingsson T, Piha J. Psychosocial functioning and psychiatric comorbidity among substance-abusing Icelandic adolescents. Nord J Psychiatry. 2001; 55(1): 43-48.
5. Ghaleiha A, Farhadi Nasab A, Zarabian M, Matinnia N. Comparative Survey of Mental Disorders and Personality Characteristics in Persons With Drug Dependent and Non Drug Dependent in Hamadan, Iran. Sci JHamdan UnivMedSci. 2008; 15(2): 42-47.
6. Troisi A, Pasini A, Saracco M, Spalletta G. Psychiatric symptoms in male cannabis users not using other illicit drugs. Addiction. 1998; 93(4): 487-492.
7. Benshoff JJ, Harrawood LK, Koch DS. Substance abuse and the elderly: Unique issues and concerns. Journal of Rehabilitation. 2003; 69(2): 43-8.
8. Benshoff JJ, Roberto KA. Alcoholism in the elderly: Clinical issues. Clinical Gerontologist. 1988; 7(2): 3-14.
9. Rigler SK. Alcoholism in the elderly. Am Fam Physician. 2000; 61(6): 1710-6.
10. Norton ED. Counseling Substance-Abusing Older Clients. Educational Gerontology: An International Quarterly.1998; 24(4): 373-89.
11. Mohsenifar S, Mostashari G, Vaziri M. Protocol for the treatment of opioid dependence with agonist drugs. 2 ed. Tehran Ministry of Health; 2006 (in persian).
12. Jewell NP. Goodness of Fit Test for Logistic Regression Models and Model Building. Statistic for Epidemiology. Washington DC: Chapman & Hall/CRC; 2004: 243-255.
13. Mohammad Khani P. Clinical strucctured interview for DSM-IV-TR disorders. Tehran: Danjeh; 2010.
14. Spitzer RL, Williams JB, Gibbon M, First MB. The structured clinical interview for DSM-III-R (SCID): I: history, rationale, and description. Archives of General Psychiatry. 1992; 49(8): 624-629.
15. Skre I, Onstad S, Torgersen S, Kringlen E. High interrater reliability for the Structured Clinical Interview for DSM-III-R Axis I (SCID-I). Acta Psychiatrica Scandinavica. 1991; 84(2): 167-173.
16. Lobbestael J, Leurgans M, Arntz A. Inter-rater reliability of the Structured Clinical Interview for DSM-IV Axis I disorders (SCID I) and Axis II disorders (SCID II). Clinical Psychology & Psychotherapy. 2011; 18(1): 75-79.
17. Martin CS, Pollock NK, Bukstein OG, Lynch KG. Inter-rater reliability of the SCID alcohol and substance use disorders section among adolescents. Drug and Alcohol Dependence 2000; 59(2): 173-176.
18. Kranzler HR, Kadden RM, Burleson JA, Babor TF, Apter A, Rounsaville BJ. Validity of psychiatric diagnoses in patients with substance use disorders: Is the interview more important than the interviewer? Comprehensive Psychiatry. 1995; 36(4): 278-288.
19. Sharifi V, Assadi SM, Mohammadi MR, Amini H, Kaviani H, Semnani Y, et al. A persian translation of the structured clinical interview for diagnostic and statistical manual of mental disorders: psychometric properties. Comprehensive Psychiatry. 2009; 50(1): 86-91.
20. Ghanizadeh A, Ashkani H, Maany I. Comorbidity of psychiatric disorders in Iranian treatment-seeking opioid addicts. Irn J Med Sci. 2000; 25: 25-30.
21. Hoseini SH, Zarghami M, Mousavi SE, Nateghi G, Masoudzade A. Study on the simultaneity of the substance abuse with psychiatric disorder in referred outpatients to psychiatryclinic of zare hospital for period of one year. Journal ofMazandaran University Of MedicalSciences. 2008; 18(67): 67-74 (In persian).
22. Ghoreishi FS, Ahmadvand A, Sepehrmanesh Z. Surveying Mental Health Status of IV Drug Abusers in Kashan Prison in 2007. Pajoohandeh Journal. 2010; 15(2): 67-71.
23. Goreishizade SMA, Torabi K. Study of mental illness combined with addiction in 200 patients referred to the center for drug abusers in Tabriz. Journal of Tabriz University of Medical Sciences. 2002; 3(55):49-53 (In Persian).
24. Bartels SJ, Blow FC, Citters ADV, Brockmann LM. Dual Diagnosis Among Older Adults: Co-Occurring Substance Abuse and Psychiatric Illness. Journal of Dual Diagnosis. 2006; 2(3): 9-30.
25. Mohammadi M-R, Davidian H, Noorbala AA, Malekafzali H, Nagha-vi HR, Pouretemad HR, et al. An epidemiological study of psychiatric. disorder in Iran, 2001. Hakim 2003; 6(1): 55-65.
26. Mohammadi M, Rahgozar M, Bagheri Yazdi A, Naghavi H, Pour Etemad HR, Amini H, et al. Epidemiological study of psychiatric disorder in Tehran Province. Iranian Journal of Psychiatry and Clinical Psychology (IJPCP). 2003; 9(2): 4-13.
27. Bartels SJ, Blow FC, Van Citters AD, Brockmann LM. Dual diagnosis among older adults: Co-occurring substance abuse and psychiatric illness. Journal of Dual Diagnosis. 2006; 2(3): 9-30.
28. Rosen D, Smith ML, Reynolds CF. The prevalence of mental and physical health disorders among older methadone patients. The American Journal of Geriatric Psychiatry. 2008; 16(6): 488-497.
29. Adamson SJ, Todd FC, Douglas Sellman J, Huriwai T, Porter J. Coexisting psychiatric disorders in a New Zealand outpatient alcohol and other drug clinical population. Australian and New Zealand Journal. of Psychiatry. 2006; 40(2): 164-170.
30. Goldner EM, Lusted A, Roerecke M, Rehm J, Fischer B. Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: systematic review and meta-analyses. AddictiveBehaviors. 2014; 39(3): 520-531.
31. Heidari J, Hoseini SH, Hedayat J, Janati Y, Mohammadpur R, Mahmudi G. Psychosocial status of addicts in Sari township in 2004. JournalofMazandaran University of Medical Sciences. 2006; 52: 109-116.
32. Gum AM, King-Kallimanis B, Kohn R. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication. The American Journal of Geriatric Psychiatry. 2009; 17(9): 769-781.
33. Vandad Sharifi M, Hajebi A, Radgoodarzi R. Twelve-month prevalence and correlates of psychiatric disorders in Iran: The Iranian Mental Health Survey, 2011. Archives of Iranian Medicine. 2015; 18(2): 76.
34. Manzouri L, Babak A, Merasi M. The depression status of the elderly and it’s related factors in Isfahan in 2007. Iranian Journal of Ageing. 2010; 4(4): 27-33.
35. Sohrabi MB, Zolfaghari P, Mahdizade F, Aghayan S-M, Ghasemian-Aghmashhadi M, Shariati Z, et al. Evaluation and comparison of cognitive state and depression in elderly admitted in sanitarium with elderly sited in personal home. Knowledge & health 2008; 3(2): 27-31.
36. Sajadi H, Mohaqeqi Kamal H, Vameghi M, Forozan AS, Rafei H, Nosratabadi M. Systematic review of prevalence and risk factors associated with depression and its treatment in Iranian elderly. Iranian Journal of Ageing. 2013; 7(4): 7-15.
37. Aranda MP, Chae DH, Lincoln KD, Taylor RJ, Woodward AT, Chatters LM. Demographic correlates of DSM-IV major depressive disorder among older African Americans, Black Caribbeans, and non-Hispanic Whites: results from the National Survey of American Life. International Journal of Geriatric Psychiatry. 2012; 27(9): 940-947.
38. Djernes J. Prevalence and predictors of depression in populations of elderly: a review. Acta Psychiatrica Scandinavica. 2006; 113(5): 372-387.
39. Steffens DC, Skoog I, Norton MC, Hart AD, Tschanz JT, Plassman BL, et al. Prevalence of depression and its treatment in an elderly population: the Cache County study. Archives of General Psychiatry. 2000; 57(6): 601-607.
40. Daneshmandan N, Narenjiha H, Tehrani K, Assari S, Khoddami-Vishteh HR. Initiation to the first drug use among substance-dependent persons in Iran. Substance Use & Misuse. 2011; 46(9): 1124-1141.
41. Stefanis N, Delespaul P, Henquet C, Bakoula C, Stefanis C, Van Os J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004; 99(10): 1333-41.
42. Odgers CL, Caspi A, Nagin DS, Piquero AR, Slutske WS, Milne BJ, et al. Is it important to prevent early exposure to drugs and alcohol among adolescents? Psychological Science. 2008; 19(10): 1037-1044.
43. Thomasius R, Sack PM, Petersen KU. DSM-iv Axis-i comorbidity among illicit drug users seeking treatment for substance use disorders: results from the Multi-centre Study of Psychiatric Comorbidity in Drug Addicts (MUPCDA). Mental Health and Substance Use: Dual diagnosis 2010; 3(3): 182-192.
44. Abasi A, Taziki SA, Moradi A. The prototype of drug mis.abused of opioids in the self-introduced addicts in Gorgan (North-East of Iran). Journal of Gorgan University of Medical Science 2006; 8(1): 22-27 (In Persian).
45. Haydari J, Jafari H, Hosseini SH, Janati Y, Mohammadpour TR, Mahmoudi G. Syudy on the Psychosocial condition of addicts in Sari township in 2004. Mazandaran University of Medical Sciences. 2006; 16(52): 109-116.
46. Rahimi MA. Prevalence and patterns of substance use and addiction in women in Iran. Social Welfare Quarterly. 2004; 3(12): 205-225 (in persian).
47. Ahmadi J, Farrashbandi H, Majdi B, Mahdavi S, Babaee MA, Menzies P, et al. Prevalence of mood and anxiety disorders in a sample of Iranian outpatient opioid addicts. Higher Education 2005; 43: 5-7.
48. Hojati H, Alustani S, Akhundzade G, heidari B, Sharifnia SH. Study of Mental Health and Its Relation with Quality of Life in Addicts. Journal of Shaheed Sadoughi University of Medical Sciences. 2010; 18(3 Suppl 1): 207-214 (In Persian).
49. Asayesh H, Jahahgir F, Qorbani M, et al. Substance Abuse and Correlation between of Route of Administration and Age Factors in Substance Abuser. Journal of Research Development in Nursing & Midwifery. 2012; 9(2): 82-89.
50. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. The NSDUH Report: Illicit Drug Use among Older Adults. 2011. Available from: URL: http://oas.samhsa.gov.